Senti Biosciences Holdings, Inc. (SNTI)
0.2239
0.00 (0.00%)
USD |
NASDAQ |
Oct 19, 16:00
0.22
0.00 (0.00%)
After-Hours: 20:00
Senti Biosciences Holdings EPS Diluted (Quarterly) : -0.4094 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4094 |
| March 31, 2026 | -0.1363 |
| December 31, 2025 | -0.5284 |
| September 30, 2025 | -0.6911 |
| June 30, 2025 | -0.5649 |
| March 31, 2025 | -1.409 |
| December 31, 2024 | -0.672 |
| September 30, 2024 | -6.307 |
| June 30, 2024 | -2.450 |
| March 31, 2024 | -2.650 |
| December 31, 2023 | -4.191 |
| Date | Value |
|---|---|
| September 30, 2023 | -3.356 |
| June 30, 2023 | -4.223 |
| March 31, 2023 | -4.248 |
| December 31, 2022 | -4.155 |
| September 30, 2022 | -3.832 |
| June 30, 2022 | -8.591 |
| March 31, 2022 | -37.23 |
| December 31, 2021 | -4.848 |
| September 30, 2021 | -38.85 |
| June 30, 2021 | -41.19 |
| March 31, 2021 | -0.0004 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0017 |
| Brainstorm Cell Therapeutics, Inc. | -0.3494 |
| Summit Therapeutics, Inc. | -0.2772 |
| Kezar Life Sciences, Inc. | -0.7838 |
| Protara Therapeutics, Inc. | -0.3552 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.75M |
| Revenue (Quarterly) | 0.017M |
| Total Expenses (Quarterly) | 12.77M |
| Enterprise Value | 20.77M |
| Gross Profit Margin (Quarterly) | -3.82K% |
| Profit Margin (Quarterly) | -75.00K% |
| Earnings Yield | -788.4% |
| Normalized Earnings Yield | -802.86 |